Vertex Pharmaceuticals is capturing the attention of investors with its expansion into pain management and cell/gene therapies. With positive earnings ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Monday.com's impressive Q4 results, including exceeding earnings and revenue expectations, did not prevent a stock slump. However, the company remains ...